endocrinology

A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.

Pfizer researchers are developing new treatments to target breast cancer tumors that flourish in the presence of hormones.

Inhibiting an enzyme variant that contributes to severe COVID-19 in men holds promise for treating SARS-CoV-2 infections. 

Aeterna has obtained an exclusive license from The University of Sheffield to IP relating to parathyroid hormone fusion polypeptides